PMDA — authorised 4 July 2014
- Status: approved
🇯🇵 Jublia in Japan
PMDA authorised Jublia on 4 July 2014
Marketing authorisations
PMDA
- Application: Clenafin
- Local brand name: Clenafin
- Status: approved
Jublia in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in Japan
Frequently asked questions
Is Jublia approved in Japan?
Yes. PMDA authorised it on 4 July 2014; PMDA has authorised it.
Who is the marketing authorisation holder for Jublia in Japan?
Bausch Health is the originator. The local marketing authorisation holder may differ — check the official source linked above.